Boston Scientific (NYSE:BSX) recently updated the directions for use and warnings for its pelvic mesh products, classifying the meshes as permanent implants and warning of complications related to removals.
The Marlborough, Mass.-based company added new precautions to the directions for the meshes, warning that that “regardless of the route of delivery,” the meshes have been associated with “erosion” which may require surgical removal.
“Complete removal of mesh may not be possible and additional surgeries may not always fully correct the complications,” the company wrote in its updated guidelines.
